NAVBQ (Navidea Biopharmaceuticals) Accounts Payable: $2.07 Mil (As of Sep. 2023)


NAVBQ Navidea Biopharmaceuticals Inc NAVBQ
16 GF Score
Price $0.00
View Full Analysis

What is Navidea Biopharmaceuticals Accounts Payable?

Navidea Biopharmaceuticals NAVBQ 16 Accounts Payable is $2.07 Mil as of Sep. 2023. GuruFocus rates NAVBQ with a GF Score™ of 16/100.

Navidea Biopharmaceuticals's Accounts Payable for the quarter that ended in Sep. 2023 was $2.07 Mil.

Navidea Biopharmaceuticals's quarterly Accounts Payable declined from Mar. 2023 ($3.17 Mil) to Jun. 2023 ($2.01 Mil) but then increased from Jun. 2023 ($2.01 Mil) to Sep. 2023 ($2.07 Mil).

Navidea Biopharmaceuticals's annual Accounts Payable increased from Dec. 2020 ($1.16 Mil) to Dec. 2021 ($1.42 Mil) and increased from Dec. 2021 ($1.42 Mil) to Dec. 2022 ($2.12 Mil).

Navidea Biopharmaceuticals Accounts Payable Related Terms

Navidea Biopharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Navidea Biopharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Navidea Biopharmaceuticals Accounts Payable Chart

Navidea Biopharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 1.11 1.16 1.42 2.12

Navidea Biopharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.74 2.12 3.17 2.01 2.07
NAVBQ
16GF Score
Navidea Biopharmaceuticals Inc NAVBQ
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Navidea Biopharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $2.07 Mil mean?
Navidea Biopharmaceuticals (NAVBQ) has a Accounts Payable of $2.07 Mil as of Sep. 2023. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Navidea Biopharmaceuticals and its competitors.
Is Navidea Biopharmaceuticals' Accounts Payable too high?
Navidea Biopharmaceuticals' current Accounts Payable is $2.07 Mil. Overall, Navidea Biopharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Navidea Biopharmaceuticals' Accounts Payable compare to PKBO and RSPI?
Navidea Biopharmaceuticals' Accounts Payable of $2.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Navidea Biopharmaceuticals and its competitors. Navidea Biopharmaceuticals's current Accounts Payable is $2.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Navidea Biopharmaceuticals stock overvalued right now?
Navidea Biopharmaceuticals (NAVBQ) has a current Accounts Payable of $2.07 Mil. The current Accounts Payable is $2.07 Mil. Navidea Biopharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Navidea Biopharmaceuticals (NAVBQ), the current Accounts Payable is $2.07 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Navidea Biopharmaceuticals Business Description

Address 4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552
Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.
16GF Score

Get the complete analysis for NAVBQ

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price